AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

Lexaria Bioscience Corp. Director's Dealing 2014

Nov 14, 2014

34983_dirs_2014-11-14_f65249b6-fb41-450b-bd51-ff7dd76d0eb5.zip

Director's Dealing

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: LEXARIA CORP. (LXRP)
CIK: 0001348362
Period of Report: 2010-01-20

Reporting Person: BUNKA CHRISTOPHER (Director, President and CEO, 10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2014-11-13	Common Shares	P	73605	$0.06	Acquired	4881819	Indirect
2014-11-13	Common Shares	P	100000	$0.064	Acquired	4981819	Indirect
2014-11-13	Common Shares	P	100000	$0.065	Acquired	5081819	Indirect

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Shares	1488561	Direct
Common Shares	3219586	Indirect
Common Shares	4808214	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Options	$0.2	2015-01-20	Common Shares (500000)	500000	Direct
Stock Options	$0.35	2016-07-11	Common Shares (200000)	700000	Direct
Common Shares	$0.1	2018-06-18	Common Shares (225000)	925000	Direct
Warrants	$0.25	2015-09-21	Common Shares (100067)	1025067	Direct